Citi has initiated coverage of EyePoint Pharmaceuticals (NASDAQ:EYPT) with a buy rating, stating it sees the company's drug ...
With top U.S. banks scheduled to commence their fourth-quarter earnings next week, Morgan Stanley has named Citi its top pick ...
This story was excerpted from Anthony DiComo’s Mets Beat newsletter, written this week by Bill Ladson. To read the full newsletter, click here. And subscribe to get it regularly in your inbox.